Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Prediction and validation of common targets in atherosclerosis and non-small cell lung cancer influenced by atorvastatin

Fig. 5

The relationship between overall survival and MMP9, MMP12, CD36, and FABP4 expression in patients with lung cancer. A MMP9 high expression was significantly correlated with lower overall survival (OS) rates in patients with lung cancer (p = 0.046). B The high expression of MMP9 was significantly correlated with the low incidence of OS in patients with LUSC (p = 0.01). C The high expression of MMP12 was significantly correlated with low OS rates in patients with LUAD (p = 0.03). D The high expression of MMP12 was significantly correlated with lower OS rates in patients with LUSC (p = 0.01). E The high expression of CD36 was significantly correlated with lower OS rates in patients with LUSC (p = 0.05). F The high expression of FABP4 was significantly correlated with lower OS rates in patients with LUSC (p = 0.03)

Back to article page